Lisa M. Pasterk
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice.
Journal: Thrombosis research
Published: December 08, 2022
Endothelial SIRT6 deficiency promotes arterial thrombosis in mice.
Journal: Journal of molecular and cellular cardiology
Published: June 01, 2022
Reduced adrenal stress response in patients on PCSK9 inhibitor therapy.
Journal: Atherosclerosis
Published: August 11, 2020
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
Journal: Thrombosis research
Published: September 25, 2018
Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity.
Journal: Cardiovascular research
Published: December 29, 2017
Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation.
Journal: Scientific reports
Published: November 15, 2016
The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.
Journal: Vascular pharmacology
Published: October 21, 2015
Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.
Journal: Scientific reports
Published: August 21, 2015
Mild endothelial dysfunction in Sirt3 knockout mice fed a high-cholesterol diet: protective role of a novel C/EBP-β-dependent feedback regulation of SOD2.
Journal: Basic research in cardiology
Published: July 22, 2015
Last Updated: 09/26/2026